State of Alaska Department of Revenue’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.5M Sell
232,583
-10,001
-4% -$2.15M 0.58% 23
2026
Q1
$52.8M Buy
242,584
+775
+0.3% +$172K 0.57% 22
2025
Q4
$55.3M Sell
241,809
-12,740
-5% -$2.9M 0.59% 20
2025
Q3
$58.9M Sell
254,549
-17,966
-7% -$3.66M 0.6% 20
2025
Q2
$50.6M Sell
272,515
-8,406
-3% -$1.56M 0.54% 23
2025
Q1
$58.9M Buy
280,921
+5,307
+2% +$1.03M 0.67% 20
2024
Q4
$49M Sell
275,614
-24,120
-8% -$4.43M 0.55% 21
2024
Q3
$59.2M Sell
299,734
-11,910
-4% -$2.22M 0.63% 18
2024
Q2
$53.5M Buy
311,644
+15,885
+5% +$2.63M 0.6% 20
2024
Q1
$53.9M Sell
295,759
-10,235
-3% -$1.76M 0.61% 20
2023
Q4
$47.4M Sell
305,994
-13,555
-4% -$1.98M 0.56% 21
2023
Q3
$47.6M Sell
319,549
-8,590
-3% -$1.26M 0.6% 21
2023
Q2
$44.2M Buy
328,139
+11,369
+4% +$1.67M 0.53% 24
2023
Q1
$50.5M Sell
316,770
-3,691
-1% -$564K 0.6% 22
2022
Q4
$51.8M Buy
320,461
+1,417
+0.4% +$217K 0.64% 23
2022
Q3
$42.8M Sell
319,044
-8,438
-3% -$1.21M 0.58% 22
2022
Q2
$50.2M Buy
327,482
+20,601
+7% +$3.15M 0.61% 20
2022
Q1
$49.7M Sell
306,881
-7,731
-2% -$1.12M 0.52% 28
2021
Q4
$42.6M Sell
314,612
-16,018
-5% -$1.89M 0.41% 40
2021
Q3
$35.7M Buy
330,630
+25,864
+8% +$2.96M 0.36% 48
2021
Q2
$34.3M Buy
304,766
+4,372
+1% +$492K 0.35% 50
2021
Q1
$32.5M Buy
300,394
+2,354
+0.8% +$252K 0.35% 50
2020
Q4
$31.9M Sell
298,040
-10,150
-3% -$975K 0.36% 48
2020
Q3
$27M Sell
308,190
-39,517
-11% -$3.72M 0.33% 58
2020
Q2
$34.1M Buy
347,707
+90,797
+35% +$7.99M 0.44% 37
2020
Q1
$19.6M Buy
256,910
+13,874
+6% +$1.18M 0.31% 64
2019
Q4
$21.5M Sell
243,036
-19,968
-8% -$1.66M 0.28% 66
2019
Q3
$19.9M Buy
263,004
+60,664
+30% +$4.16M 0.27% 69
2019
Q2
$14.7M Buy
202,340
+975
+0.5% +$76.6K 0.25% 95
2019
Q1
$16.2M Sell
201,365
-26,439
-12% -$2.16M 0.29% 79
2018
Q4
$21M Buy
227,804
+1,942
+0.9% +$171K 0.41% 48
2018
Q3
$21.4M Sell
225,862
-7,537
-3% -$715K 0.36% 53
2018
Q2
$21.6M Buy
233,399
+44,276
+23% +$4.32M 0.39% 45
2018
Q1
$17.9M Buy
189,123
+13,560
+8% +$1.49M 0.37% 54
2017
Q4
$17M Buy
175,563
+149,538
+575% +$14.1M 0.41% 48
2017
Q3
$2.31M Buy
26,025
+9,985
+62% +$760K 0.12% 173
2017
Q2
$1.16M Buy
+16,040
New +$1.08M 0.08% 226
2016
Q3
Sell
-14,970
Closed -$926K 356
2016
Q2
$926K Sell
14,970
-700
-4% -$42.7K 0.1% 204
2016
Q1
$895K Buy
+15,670
New +$873K 0.09% 210
2015
Q4
Sell
-12,170
Closed -$662K 349
2015
Q3
$662K Buy
+12,170
New +$792K 0.14% 153
2015
Q1
Sell
-5,310
Closed -$347K 228
2014
Q4
$347K Sell
5,310
-830
-14% -$52.3K 0.07% 182
2014
Q3
$354K Sell
6,140
-2,600
-30% -$144K 0.08% 162
2014
Q2
$493K Buy
8,740
+580
+7% +$30.4K 0.1% 153
2014
Q1
$419K Buy
+8,160
New +$412K 0.09% 157

Other funds holding ABBV

State of Alaska Department of Revenue's ABBV Position: Q2 2026 in Review

State of Alaska Department of Revenue reduced its AbbVie (ABBV) stake by 4.1% in Q2 2026, selling an estimated $2.15M and leaving 232,583 shares worth $58.5M. The position accounts for 0.58% of the portfolio, ranked #23.

State of Alaska Department of Revenue first reported a position in ABBV in Q1 2014 and has held it in 44 quarters since. The position peaked at $59.2M in Q3 2024. 3,455 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • State of Alaska Department of Revenue held 232,583 shares of AbbVie worth $58.5M as of Q2 2026.
  • State of Alaska Department of Revenue sold 10,001 AbbVie shares in Q2 2026, an estimated $2.15M.
  • AbbVie made up 0.58% of State of Alaska Department of Revenue's portfolio in Q2 2026, its #23 holding.
  • State of Alaska Department of Revenue first reported a position in AbbVie in Q1 2014 and has held it in 44 quarters since.
  • State of Alaska Department of Revenue's AbbVie position peaked at $59.2M in Q3 2024.
  • 3,455 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q2 2026, filed 20 Jul 2026.